Related Experiment Video

Updated: Aug 14, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Adjuvant multimodality immunotherapy in resected high-risk pancreatic ductal adenocarcinoma

Arunkumar Krishnan1, Diptasree Mukherjee1

  • 1Department of Supportive Oncology, Atrium Health Levine Cancer, Charlotte, NC, USA.

Translational Gastroenterology and Hepatology
|August 13, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
GM-CSF-secreting pancreatic tumor vaccine (GVAX)Pancreatic ductal adenocarcinoma (PDAC)adjuvant immunotherapystereotactic body radiation therapy (SBRT)tumor microenvironment

More Related Videos

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.